Technimark’s facility in Longford, Ireland [Photo courtesy of Technimark]
Technimark has become the first company in Ireland to earn MedAccred program accreditation.
Technimark Ireland Ltd. — a subsidiary of Asheboro, North Carolina-based Technimark — won MedAccred accreditation for both plastics injection molding and plastics mechanical assembly at its facility in Longford, Ireland.
“The accreditation is widely recognized as a benchmark of excellence in the medical device industry, as it demonstrates compliance to industry standards, customer requirements and best practices,” MedAccred VP Bob Lizewski said in a news release. “The MedAccred program is regarded by the industry as a foundation stone for building risk management strategy.”
The news comes as medtech manufacturers and their partners continue to expand in Ireland. In fact, the idea for the MedAccred program originated in Cork, Ireland, from Simon Adam (then at Johnson & Johnson’s DePuy Synthes) in 2010.
Technimark previously won MedAccred accreditation for its facilities in Latrobe, Pennsylvania, and El Paso, Texas. Technimark Healthcare Sales SVP John Rugari said the latest accreditation in Ireland demonstrates the medtech supplier’s “commitment to global quality.”
“This certification will enhance process capability, manufacturing monitoring and process validation,” Rugari said in the news release. “We use all resources available in our pursuit of best-in-class quality.”
The MedAccred program is administered by the Performance Review Institute with funding and audit direction from the world’s largest medical device manufacturers, including Baxter, Becton Dickinson, Boston Scientific, Edwards Lifesciences, Medtronic, Philips, Roche Diagnostics and Stryker.
Founded in 1983 as a small industrial molder, Technimark now says it is one of the largest independent injection molders in the world. Medtech customers include developers and manufacturers of medical devices (including drug delivery devices), diagnostics and consumer healthcare products.